Netherlands - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Voluntary Health Insurance Schemes
Since 2014, Netherlands Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Voluntary Health Insurance Schemes fell by 18.4% year on year. At €1.41 Per Capita in 2019, the country was number 15 among other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Voluntary Health Insurance Schemes. Netherlands is overtaken by Lithuania, which was number 14 with €1.99 Per Capita and is followed by Germany with €1.06 Per Capita. Slovenia topped the ranking with €84.89 Per Capita in 2019, a decrease of 0.2% compared to 2018. Switzerland, France and Liechtenstein respectively ranked number 2, 3 and 4 in this ranking. Liechtenstein witnessed the best average annual growth at +27.3% per year, while Netherlands recorded the worst performance at -18.4% per year.
Loading...
Date | Euros Per Capita |
---|---|
2019 | 1.41 |
2018 | 3.60 |
2017 | 3.68 |
2016 | 3.93 |
2015 | 4.30 |
How does Netherlands rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Voluntary Health Insurance Schemes?
# | 20 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Slovenia
|
84.89 | 2019 | -0.2 % | +2.2 % | View data | |
2 |
#2
Switzerland
|
71.18 | 2019 | -9.9 % | +18.5 % | View data | |
14 |
#14
Lithuania
|
1.99 | 2019 | +1.5 % | +13.4 % | View data | |
15 |
#15
Netherlands
|
1.41 | 2019 | -60.8 % | -18.4 % | View data | |
16 |
#16
Germany
|
1.06 | 2018 | +1.9 % | +0.2 % | View data |